TY - JOUR AU - Iczkowski, K. A. AU - Pantazis, C. G. AU - Collins, J. PY - 1997 DA - 1997// TI - The loss of expression of CD44 standard and variant isoforms is related to prostatic carcinoma development and tumor progression JO - J Urol Pathol VL - 6 ID - Iczkowski1997 ER - TY - JOUR AU - Iczkowski, K. A. AU - Bai, S. AU - Pantazis, C. G. PY - 2003 DA - 2003// TI - Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level JO - Anticancer Res VL - 23 ID - Iczkowski2003 ER - TY - JOUR AU - Omara-Opyene, A. L. AU - Qiu, J. AU - Shah, G. V. AU - Iczkowski, K. A. PY - 2004 DA - 2004// TI - Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18 JO - Lab Invest VL - 84 UR - https://doi.org/10.1038/labinvest.3700112 DO - 10.1038/labinvest.3700112 ID - Omara-Opyene2004 ER - TY - JOUR AU - Iczkowski, K. A. AU - Omara-Opyene, A. L. AU - Shah, G. V. PY - 2006 DA - 2006// TI - The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression JO - Anticancer Res VL - 26 ID - Iczkowski2006 ER - TY - JOUR AU - Vis, A. N. AU - van Rhijn, B. W. AU - Noordzij, M. A. AU - Schröder, F. H. AU - Kwast, T. H. v. a. n. d. e. r. PY - 2002 DA - 2002// TI - Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer JO - J Pathol VL - 197 UR - https://doi.org/10.1002/path.1084 DO - 10.1002/path.1084 ID - Vis2002 ER - TY - JOUR AU - Vis, A. N. AU - Noordzij, M. A. AU - Fitoz, K. AU - Wildhagen, M. F. AU - Schröder, F. H. AU - Kwast, T. H. v. a. n. d. e. r. PY - 2000 DA - 2000// TI - Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer JO - J Urol VL - 164 UR - https://doi.org/10.1016/S0022-5347(05)66989-3 DO - 10.1016/S0022-5347(05)66989-3 ID - Vis2000 ER - TY - JOUR AU - Harrison, G. M. AU - Davies, G. AU - Martin, T. A. AU - Mason, M. D. AU - Jiang, W. G. PY - 2006 DA - 2006// TI - The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells JO - Oncol Rep VL - 15 ID - Harrison2006 ER - TY - JOUR AU - Iczkowski, K. A. AU - Omara-Opyene, A. L. AU - Kulkarni, T. R. AU - Pansara, M. AU - Shah, G. V. PY - 2005 DA - 2005// TI - Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion JO - Anticancer Res VL - 25 ID - Iczkowski2005 ER - TY - JOUR AU - Miyake, H. AU - Hara, I. AU - Okamoto, I. AU - Gohji, K. AU - Yamanaka, K. AU - Arakawa, S. AU - Saya, H. AU - Kamidono, S. PY - 1998 DA - 1998// TI - Interaction between CD44 and hyaluronic acid regulates human prostate cancer development JO - J Urol VL - 160 UR - https://doi.org/10.1016/S0022-5347(01)62613-2 DO - 10.1016/S0022-5347(01)62613-2 ID - Miyake1998 ER - TY - JOUR AU - Brummelkamp, T. R. AU - Bernards, R. AU - Agami, R. PY - 2002 DA - 2002// TI - Stable suppression of tumorigenicity by virus-mediated RNA interference JO - Cancer Cell VL - 2 UR - https://doi.org/10.1016/S1535-6108(02)00122-8 DO - 10.1016/S1535-6108(02)00122-8 ID - Brummelkamp2002 ER - TY - JOUR AU - Morrison, H. AU - Sherman, L. S. AU - Legg, J. AU - Banine, F. AU - Isacke, C. AU - Haipek, C. A. AU - Gutmann, D. H. AU - Ponta, H. AU - Herrlich, P. PY - 2001 DA - 2001// TI - The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 JO - Genes Dev VL - 15 UR - https://doi.org/10.1101/gad.189601 DO - 10.1101/gad.189601 ID - Morrison2001 ER - TY - JOUR AU - Horiguchi, A. AU - Zheng, R. AU - Shen, R. AU - Nanus, D. M. PY - 2008 DA - 2008// TI - Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells JO - Prostate VL - 68 UR - https://doi.org/10.1002/pros.20760 DO - 10.1002/pros.20760 ID - Horiguchi2008 ER - TY - JOUR AU - Chan, W. H. AU - Wu, H. J. AU - Shiao, N. -. H. PY - 2007 DA - 2007// TI - Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2 JO - J Cell Biochem VL - 100 UR - https://doi.org/10.1002/jcb.21114 DO - 10.1002/jcb.21114 ID - Chan2007 ER - TY - JOUR AU - Robbins, E. W. AU - Travanty, E. A. AU - Yang, K. AU - Iczkowski, K. A. PY - 2008 DA - 2008// TI - MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells JO - BioMed Central Cancer VL - 8 ID - Robbins2008 ER - TY - JOUR AU - Harada, N. AU - Mizoi, T. AU - Kinouchi, M. AU - Hoshi, K. AU - Ishii, S. AU - Shiiba, K. AU - Sasaki, I. AU - Matsuno, S. PY - 2001 DA - 2001// TI - Introduction of antisense CD44s cDNA downregulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells JO - Int J Cancer VL - 91 UR - https://doi.org/3.0.CO;2-D DO - 3.0.CO;2-D ID - Harada2001 ER - TY - JOUR AU - Laemmli, U. K. PY - 1970 DA - 1970// TI - Cleavage of structural proteins during the assembly of the head of bacteriophage T4 JO - Nature VL - 227 UR - https://doi.org/10.1038/227680a0 DO - 10.1038/227680a0 ID - Laemmli1970 ER - TY - JOUR AU - Orian-Rousseau, V. AU - Chen, L. AU - Sleeman, J. P. AU - Herrlich, P. AU - Ponta, H. PY - 2002 DA - 2002// TI - CD44 is required for two consecutive steps in HGF/c-Met signaling JO - Genes Dev VL - 16 UR - https://doi.org/10.1101/gad.242602 DO - 10.1101/gad.242602 ID - Orian-Rousseau2002 ER - TY - JOUR AU - Simon, R. A. AU - di Sant'Agnese, P. A. AU - Huang, L. S. AU - Xu, H. AU - Yao, J. L. AU - Yang, Q. AU - Liang, S. AU - Liu, J. AU - Yu, R. AU - Cheng, L. AU - Oh, W. K. AU - Palapattu, G. S. AU - Wei, J. AU - Huang, J. PY - 2009 DA - 2009// TI - CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers JO - Hum Pathol VL - 40 UR - https://doi.org/10.1016/j.humpath.2008.07.014 DO - 10.1016/j.humpath.2008.07.014 ID - Simon2009 ER - TY - JOUR AU - Palapattu, G. S. AU - Wu, C. AU - Silvers, C. R. AU - Martin, H. B. AU - Williams, K. AU - Salamone, L. AU - Bushnell, T. AU - Huang, L. S. AU - Yang, Q. AU - Huang, J. PY - 2009 DA - 2009// TI - Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer JO - Prostate VL - 69 UR - https://doi.org/10.1002/pros.20928 DO - 10.1002/pros.20928 ID - Palapattu2009 ER - TY - JOUR AU - Gao, A. C. AU - Lou, W. AU - Sleeman, J. P. AU - Isaacs, J. T. PY - 1998 DA - 1998// TI - Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate JO - Cancer Res VL - 58 ID - Gao1998 ER - TY - JOUR AU - Lokeshwar, V. B. AU - Bourguignon, L. Y. PY - 1992 DA - 1992// TI - The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction JO - J Biol Chem VL - 267 ID - Lokeshwar1992 ER - TY - JOUR AU - Jiang, H. AU - Peterson, R. S. AU - Wang, W. AU - Bartnik, E. AU - Knudson, C. B. AU - Knudson, W. PY - 2002 DA - 2002// TI - A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M108654200 DO - 10.1074/jbc.M108654200 ID - Jiang2002 ER - TY - JOUR AU - Lesley, J. AU - Kincade, P. W. AU - Hyman, R. PY - 2000 DA - 2000// TI - The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding JO - Eur J Immunol VL - 30 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Lesley2000 ER - TY - JOUR AU - Mielgo, A. AU - van Driel, M. AU - Bloem, A. AU - Landmann, L. AU - Günthert, U. PY - 2006 DA - 2006// TI - A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms JO - Cell Death Differ VL - 13 UR - https://doi.org/10.1038/sj.cdd.4401763 DO - 10.1038/sj.cdd.4401763 ID - Mielgo2006 ER - TY - JOUR AU - Klingbeil, P. AU - Marhaba, R. AU - Jung, T. AU - Kirmse, R. AU - Ludwig, T. AU - Zöller, M. PY - 2009 DA - 2009// TI - CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance JO - Mol Cancer Res VL - 7 UR - https://doi.org/10.1158/1541-7786.MCR-08-0207 DO - 10.1158/1541-7786.MCR-08-0207 ID - Klingbeil2009 ER - TY - JOUR AU - Liu, W. AU - Wei, W. AU - Winer, D. AU - Bamberger, A. M. AU - Bamberger, C. AU - Wagener, C. AU - Ezzat, S. AU - Asa, S. L. PY - 2007 DA - 2007// TI - CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210077 DO - 10.1038/sj.onc.1210077 ID - Liu2007 ER - TY - JOUR AU - Jantscheff, P. AU - Esser, N. AU - Graeser, R. AU - Ziroli, V. AU - Kluth, J. AU - Unger, C. AU - Massing, U. PY - 2009 DA - 2009// TI - Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory DU145 and PC-3 prostate cancer xenografts JO - Prostate VL - 69 UR - https://doi.org/10.1002/pros.20964 DO - 10.1002/pros.20964 ID - Jantscheff2009 ER - TY - JOUR AU - Bai, Y. AU - Liu, Y. AU - Wang, H. AU - Xu, Y. AU - Stamenkovic, I. AU - Yu, Q. PY - 2007 DA - 2007// TI - Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressive activity of merlin JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1209849 DO - 10.1038/sj.onc.1209849 ID - Bai2007 ER - TY - JOUR AU - Katagiri, Y. U. AU - Sleeman, J. AU - Fujii, H. AU - Herrlich, P. AU - Hotta, H. AU - Tanaka, K. AU - Chikuma, S. AU - Yagita, H. AU - Okumura, K. AU - Murakami, M. AU - Saiki, I. AU - Chambers, A. F. AU - Uede, T. PY - 1999 DA - 1999// TI - CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis JO - Cancer Res VL - 59 ID - Katagiri1999 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/10/16/prepub UR - http://www.biomedcentral.com/1471-2407/10/16/prepub ID - ref30 ER -